title: Proliferative effects of Chishao on Schwann cells are FGF-uPA, and ERK- and JNK-dependent.
abstract: This study evaluated the proliferative effects of chishao on RSC96, Schwann cells. A dose-dependent proliferative effect of chishao was obtained by methylthiazol tetrazolium (MTT), proliferating cell nuclear antigen (PCNA) Western blotting, and wound healing assays in Schwann cells administered with chishao (0-500 mg/ml), except at 500 mg/ml concentration. The chishao-treated cells also showed a dose-dependent activated fibroblast growth factor-2 (FGF-2) signaling with increased urokinase plasminogen activator (uPA) and decreased plasminogen activator inhibitor-1 (PAI-1), enhanced proliferative proteins, extracellular signal regulated kinase (ERK) and c-Jun N-terminal kinase (JNK)-signaling. Using mitogen-actvated protein kinase (MAPK)-signaling chemical inhibitors, U0126, SB203580, and SP600125, the proliferative effects of chishao on RSC cells were identified to be ERK- and JNK- signaling dependent. Based on the results, applying appropriate doses of chishao to Schwann cells would be a potential approach for enhancing neuron regeneration.
authors: Graduate Institute of Chinese Medical Science, China Medical University, Taichung, Taiwan.
authors: Kun Shan
authors: KS
authors: Huang
authors: Min-Jin
authors: MJ
authors: Lu
authors: Yueh-Sheng
authors: YS
authors: Chen
authors: Fuu-Jen
authors: FJ
authors: Tsai
authors: Wei-Wen
authors: WW
authors: Kuo
authors: Yi-Chang
authors: YC
authors: Cheng
authors: Chien-Chung
authors: CC
authors: Lin
authors: Chang-Hai
authors: CH
authors: Tsai
authors: Chih-Yang
authors: CY
authors: Huang
authors: Jaung-Geng
authors: JG
authors: Lin
authors: Hsiu-Chung
authors: HC
authors: Ou
mesh_terms: D015153:Blotting, Western; D002460:Cell Line; D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004365:Drugs, Chinese Herbal / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000378:metabolism; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism*; D006801:Humans; D048031:JNK Mitogen-Activated Protein Kinases / Q000378:metabolism; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism*; D009474:Neurons / Q000187:drug effects; D029596:Paeonia; D018517:Plant Roots; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism; D010960:Plasminogen Activators / Q000378:metabolism*; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism; D012583:Schwann Cells / Q000187:drug effects* / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism; D014945:Wound Healing / Q000187:drug effects
chemical_list: D004365:Drugs, Chinese Herbal; D004791:Enzyme Inhibitors; D017395:Plasminogen Activator Inhibitor 1; D018809:Proliferating Cell Nuclear Antigen; D016222:Fibroblast Growth Factor 2; D048049:Extracellular Signal-Regulated MAP Kinases; D048031:JNK Mitogen-Activated Protein Kinases; D020928:Mitogen-Activated Protein Kinases; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator